ROCHESTER, Minn. — Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
Epilepsy affects 60 million people worldwide and 3 million in the U.S. Approximately one-third of people with epilepsy will continue having seizures, despite taking daily medications. Seizures, the hallmark of epilepsy, are sudden events that strike patients without warning. The goal of the research is to develop an implantable device that can record brain activity continuously to forecast upcoming seizures and stimulate multiple brain regions in real time to prevent seizures before they ever occur.
MEDIA CONTACT: Duska Anastasijevic, Mayo Clinic Public Affairs, 507-284-5005, email: firstname.lastname@example.org
Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.